Intermediate Monitoring, Sample Size Reassessment, and Multi-Treatment Optimal Response-Adaptive Designs for Phase III Clinical Trials with More Than One Constraint (Q3391873): Difference between revisions
From MaRDI portal
Latest revision as of 20:46, 1 July 2024
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Intermediate Monitoring, Sample Size Reassessment, and Multi-Treatment Optimal Response-Adaptive Designs for Phase III Clinical Trials with More Than One Constraint |
scientific article |
Statements
Intermediate Monitoring, Sample Size Reassessment, and Multi-Treatment Optimal Response-Adaptive Designs for Phase III Clinical Trials with More Than One Constraint (English)
0 references
13 August 2009
0 references
constraints
0 references
ethical allocation
0 references
group sequential designs
0 references
minimization
0 references
